Miraculins Inc.; Pharmachoice; and Pear Healthcare Solutions announce that PharmaChoice will be the first pharmacy network to introduce the PreVu Non- Invasive Skin Cholesterol Point of Care (POC) Test in Ontario and Atlantic Canada, through a Phase One launch in up to 50 of its stores this February. PreVu will be introduced this February during National Heart Health Month in up to 50 PharmaChoice locations spread out across Ontario, New Brunswick, Prince Edward Island, Nova Scotia and Newfoundland, as part of a Phase One launch of the new test through the PharmaChoice network. This introductory campaign will see the PreVu POC Test conducted in-store by PharmaChoice pharmacists as part of a series of special PreVu Cardiovascular Risk Assessment Clinics.

Phase Two of the expansion will see additional PharmaChoice locations being added in the months that follow, with all participating stores anticipated to transition to offering PreVu testing as an ongoing risk assessment service available either through walk-up request or by appointment.